Evidence map›Paper›PMID 35096942›Full record

ArticleFrontiers in nutrition2021

Management of Hypercholesterolemia Through Dietary ß-glucans-Insights From a Zebrafish Model.

Adnan Hussain Gora, Saima Rehman, Viswanath Kiron, Jorge Dias, Jorge M O Fernandes, Pål Asgeir Olsvik, Prabhugouda Siriyappagouder, Ioannis Vatsos, Ulrike Schmid-Staiger, Konstantin Frick and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Microencapsulation ofFrontiers in microbiology · 2026
    Article
  5. Review
  6. ExploringMarine drugs · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Wild Mushrooms: A Hidden Treasure of Novel Bioactive Compounds.International journal of analytical chemistry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Adnan Hussain GoraFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Saima RehmanFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Viswanath KironFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Jorge DiasSPAROS Lda., Olhão, Portugal.
Jorge M O FernandesFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Pål Asgeir OlsvikFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Prabhugouda SiriyappagouderFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Ioannis VatsosFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Ulrike Schmid-StaigerFraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Innovation Field Algae Biotechnology-Development, Stuttgart, Germany.
Konstantin FrickInstitute of Interfacial Process Engineering and Plasma Technology, University of Stuttgart, Stuttgart, Germany.
Miguel CardosoMadeBiotech and NatureXtracts S.A., Caniçal, Portugal.
Nord University · NOFraunhofer Institute for Interfacial Engineering and Biotechnology · DESparos (Portugal) · PTUniversity of Stuttgart · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consumption of lipid-rich foods can increase the blood cholesterol content. β-glucans have hypocholesterolemic effect. However, subtle changes in their molecular branching can influence bioactivity. Therefore, a comparative investigation of the cholesterol-lowering potential of two β-glucans with different branching patterns and a cholesterol-lowering drug, namely simvastatin was undertaken employing the zebrafish (

Indexed as

cholesterollipidsmicroalgaeRNA-Seqzebrafishβ-glucans

Identifiers

PMID35096942
PMCPMC8790573
OpenAlexW4206363107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.